<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Q</submitter><funding>Natural Science Foundation of Guangdong Province</funding><funding>National Natural Science Foundation of China</funding><pagination>8236-8247</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7348140</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(14)</volume><pubmed_abstract>Long non-coding RNAs (lncRNAs) take various effects in cancer mostly through sponging with microRNAs (miRNAs). lncRNA NR2F1-AS1 is found to promote tumour progression in hepatocellular carcinoma, endometrial cancer and thyroid cancer. However, the role of lncRNA NR2F1-AS1 in breast cancer angiogenesis remains unknown. In this study, we found lncRNA NR2F1-AS1 was positively related with CD31 and CD34 in breast cancer through Pearson's correlation analysis, while lncRNA NR2F1-AS1 transfection promoted human umbilical vascular endothelial cell (HUVEC) tube formation. In breast cancer cells, lncRNA NR2F1-AS1 enhanced the HUVEC proliferation, tube formation and migration ability through tumour-conditioned medium (TCM). In zebrafish model, lncRNA NR2F1-AS1 increased the breast cancer cell-relate</pubmed_abstract><journal>Journal of cellular and molecular medicine</journal><pubmed_title>lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway.</pubmed_title><pmcid>PMC7348140</pmcid><funding_grant_id>81602520</funding_grant_id><funding_grant_id>2017A030313596</funding_grant_id><funding_grant_id>81702848</funding_grant_id><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Shao N</pubmed_authors><pubmed_authors>Lin Y</pubmed_authors><pubmed_authors>Kuang X</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway.</name><description>Long non-coding RNAs (lncRNAs) take various effects in cancer mostly through sponging with microRNAs (miRNAs). lncRNA NR2F1-AS1 is found to promote tumour progression in hepatocellular carcinoma, endometrial cancer and thyroid cancer. However, the role of lncRNA NR2F1-AS1 in breast cancer angiogenesis remains unknown. In this study, we found lncRNA NR2F1-AS1 was positively related with CD31 and CD34 in breast cancer through Pearson's correlation analysis, while lncRNA NR2F1-AS1 transfection promoted human umbilical vascular endothelial cell (HUVEC) tube formation. In breast cancer cells, lncRNA NR2F1-AS1 enhanced the HUVEC proliferation, tube formation and migration ability through tumour-conditioned medium (TCM). In zebrafish model, lncRNA NR2F1-AS1 increased the breast cancer cell-relate</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-06-01T02:53:25.748Z</modification><creation>2025-06-01T02:53:25.748Z</creation></dates><accession>S-EPMC7348140</accession><cross_references><pubmed>32548873</pubmed><doi>10.1111/jcmm.15499</doi></cross_references></HashMap>